Structured abstract Hypothesis Cancer stem cells (CSCs) are subpopulations of cells which could contribute to tumor growth, metastasis formation and chemoresistance. CSCs can be detected by surface markers assessed by immunohistochemistry methods. A typical surface marker for CSCs is CD44 (standard form). We assumed, that CD44(s) could serve as a prognostic factor and marker of chemoresistance in patients with epithelial ovarian cancer. The aim of study 1. To recruit group of patients with histologically verified epithelial ovarian carcinoma. 2. To evaluate prognostic significance of known prognostic factors in our series of patients. 3. To assess the expression of CD44 in specimens of primary tumors and specimens of implantation metastasis...
Background: Tumorgenicity studies show that Cancer Stem Cells (CSCs) but not their differentiated co...
Abstract 14 The lack of significant progress in treating epithelial ovarian cancer (EOC) underscores...
The clinical significance of Cluster of Differentiation 44 (CD44) remains controversial in human ova...
Structured abstract Hypothesis Cancer stem cells (CSCs) are subpopulations of cells which could cont...
Epithelial ovarian cancer stem cells (EOC stem cells) have been associated with recurrence and chemo...
Abstract Background CD44 has r...
Objective: Epithelial ovarian cancer (EOC) cells with CD44 and CK19 coexpression may represent a sub...
Ovarian cancer remains one of the most fatal pathologies among women around the world due to late di...
Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for p...
The high mortality rate associated with epithelial ovarian cancer (EOC) is due to its insidious onse...
Abstract Background Ovarian cancer is a complicated malady associated with cancer stem cells (CSCs) ...
BACKGROUND: Growing evidence supports the notion that the onset of tumorigenesis could occur through...
Ovarian cancer is the most lethal gynecological malignancy. Poor overall survival, particularly for ...
Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Cancer stem cells ...
Liang Wang, Tianmin Xu, Manhua Cui Department of Gynecology and Obstetrics, The Second Hospital of ...
Background: Tumorgenicity studies show that Cancer Stem Cells (CSCs) but not their differentiated co...
Abstract 14 The lack of significant progress in treating epithelial ovarian cancer (EOC) underscores...
The clinical significance of Cluster of Differentiation 44 (CD44) remains controversial in human ova...
Structured abstract Hypothesis Cancer stem cells (CSCs) are subpopulations of cells which could cont...
Epithelial ovarian cancer stem cells (EOC stem cells) have been associated with recurrence and chemo...
Abstract Background CD44 has r...
Objective: Epithelial ovarian cancer (EOC) cells with CD44 and CK19 coexpression may represent a sub...
Ovarian cancer remains one of the most fatal pathologies among women around the world due to late di...
Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for p...
The high mortality rate associated with epithelial ovarian cancer (EOC) is due to its insidious onse...
Abstract Background Ovarian cancer is a complicated malady associated with cancer stem cells (CSCs) ...
BACKGROUND: Growing evidence supports the notion that the onset of tumorigenesis could occur through...
Ovarian cancer is the most lethal gynecological malignancy. Poor overall survival, particularly for ...
Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Cancer stem cells ...
Liang Wang, Tianmin Xu, Manhua Cui Department of Gynecology and Obstetrics, The Second Hospital of ...
Background: Tumorgenicity studies show that Cancer Stem Cells (CSCs) but not their differentiated co...
Abstract 14 The lack of significant progress in treating epithelial ovarian cancer (EOC) underscores...
The clinical significance of Cluster of Differentiation 44 (CD44) remains controversial in human ova...